New RSV Vaccine Approved for Children 新的RSV免受呼吸道合胞病毒疫苗获批用于儿童 本文原文节选自voa,由高级健康管理师营养师药师媛的小口袋解读 U.S. officials on Monday approved the first long-acting drug to protect babies and young children against respiratory syncytial virus, or RSV. 美国周一,官方...
The CDC panel's recommendation of Pfizer's maternal vaccine was based on data from a phase three trial on nearly 7,400 participants. But mothers received the shot 24 to 36 weeks into their pregnancy in the trial, which is a wider period than the approved dosing time frame. During the ...
13.Zhu Q, McLellan JS, Kallewaard NL, et al. A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci Transl Med. 2017 May 3;9(388): eaaj1928. 14. Lobo ED, Hans...
RSV is a leading cause of infant hospitalizations in the U.S. and is also a threat inolder adults. While several potential RSV vaccines are in late-stage clinical trials in adults, there have been no such vaccines for children since the dramatic failure of a candidatevaccinein 1966. The an...
13. Zhu Q, McLellan JS, Kallewaard NL, et al. A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci Transl Med. 2017 May 3;9(388): eaaj1928. 14. Lobo ED, Hansen RJ, Balthasar JP. Antibody pharmacokinetics and pharmacodynamics. J Pharm...
In addition to their RSV vaccine,Pfizer recently acquired ReViraland the company’s portfolio of RSV therapeutics. ReViral’s therapeutic candidates focus on treating RSV infection in older adults who are more likely todie due to RSV infectionthan children....
此次CDC公布的数据通过新疫苗监测网络(New Vaccine Surveillance Network)评估所得,内容涉及2023年10月1日至2024年2月29日间,首个RSV季节中Beyfortus预防RSV相关住院治疗有效性的分析。分析显示,在699名因急性呼吸道疾病住院的婴儿中,有59名(8%)在症状出现≥7天前接受了Beyfortus。Beyfortus对于预防RSV相关住院治疗的...
13,Zhu Q, McLellan JS, Kallewaard NL, et al. A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci Transl Med. 2017 May 3;9(388): eaaj1928. 13,Lobo ED, Hansen RJ, Balthasar JP. Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci...
[2]U.S. Centers for Disease Control and Prevention. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Seas...
CDC: RSV Vaccine Recommended for Older PeopleCENTERS for Disease Control & Prevention (U.S.)RESPIRATORY syncytial virus infection vaccinesOLDER peopledoi:10.1001/jama.2023.12537Harris, EmilyJAMA: Journal of the American Medical Association